New Key Statistics Module, Z-Score and F-Score
NAS:ZVRA Key Ratios
| Market Cap $ M | 422.00 |
| Enterprise Value $ M | 422.21 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 10.42 |
| Price/Sales | 13.22 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 23.00 |
| EPS (TTM) $ | -1.68 |
| Beneish M-Score | 36.43 |
| 10-y EBITDA Growth Rate % | 34.60 |
| 5-y EBITDA Growth Rate % | 54.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.85 |
| EV-to-EBITDA | -7.33 |
| PEG | -- |
| Shares Outstanding M | 52.62 |
| Net Margin (%) | -274.10 |
| Operating Margin % | -309.83 |
| Pre-tax Margin (%) | -273.36 |
| Quick Ratio | 2.00 |
| Current Ratio | 2.00 |
| ROA % (ttm) | -46.14 |
| ROE % (ttm) | -117.77 |
| ROIC % (ttm) | -99.66 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.01 |
ZVRA Number of Guru Trades
ZVRA Volume of Guru Trades
Gurus Latest Trades with NAS:ZVRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ZVRA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zevra Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ZVRA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers